Molecular and Cytogenetic Characteristics of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) in Patients Exposed to Chemotherapy (CT) and/or Radiation (XRT)
Pinkal Desai(NewYork–Presbyterian Hospital), Gail J. Roboz(Cornell University), Hetty E. Carraway(Cleveland Clinic), Oluwatobi Odetola(Northwestern University), Bridget C. Foley, Peter Doukas(Northwestern University), Justin D. Kaner(NewYork–Presbyterian Hospital), Ellen K. Ritchie(Cornell University), Sindhusha Veeraballi(Cleveland Clinic), Michal Bar‐Natan(NewYork–Presbyterian Hospital), Jason Chua(Cornell University), Cynthia Crispino(Cornell University), Michael Samuel(NewYork–Presbyterian Hospital), Yasmin Abaza(Northwestern University)
Cited by 0
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k